LC-TEM provides a window into the nanoscale
Researchers create a device that allows more electron beam to pass through liquid samples...
List view / Grid view
Researchers create a device that allows more electron beam to pass through liquid samples...
Long-term use of some anticholinergic medications are associated with an increased risk of dementia – according to a new study led by the University of East Anglia...
A novel technique called radiation segmentectomy (RS), that delivers high doses of radiation to tumours while sparing the surrounding healthy tissue, shows promise as a curative treatment option for patients with early-stage liver cancer, according to a recent study.
Acyclic retinoid, an artificial compound derived from vitamin A, has been found to prevent the recurrence of hepatocellular carcinoma...
B&W Tek is proud to announce the QTRam™ for nondestructive and real-time pharmaceutical content and blend uniformity measurement powered by the award-winning STRaman™ technology at CPhI North America on Tuesday, April 24, 2018...
ACG’s Capsules business will showcase their range of capsules solutions at CPhI North America, an international platform that brings together Pharma industry’s leaders from drug development, drug manufacturing and bio-manufacturing...
The FDA has authorised the first test to identify the emerging pathogen Candida auris, which can cause serious infections in hospitalised patients...
Scientists have tried combining drugs in an effort to prevent resistance development that eventually leads to cancer regrowth in melanoma patients.
The FDA has announced its latest action to encourage and support the development of treatment options for people with opioid use disorder...
Researchers demonstrate hemp's ability to slow cancer growth and uncover mechanism for its cancer-fighting ability...
Mount Sinai shows the potential link between Parkinson's disease and inflammatory bowel disease, suggests anti-TNFα therapy may reduce the risk of developing Parkinson's...
Researchers have developed a vaccine for one of the most dangerous types of synthetic cathinones...
A new non-toxic method for delivering anti-cancer drugs to specific parts of the human body could mean the end of the severe side effects...
The FDA has approved Crysvita, the first drug approved to treat adults and children ages 1 year and older with x-linked hypophosphatemia, a rare, inherited form of rickets...
Complete LC/MS solution for cell culture analysis...